Found: 72
Select item for more details and to access through your institution.
Where Is the Opioid Use Epidemic in Mexico? A Cautionary Tale for Policymakers South of the US–Mexico Border.
- Published in:
- American Journal of Public Health, 2019, v. 109, n. 1, p. 73, doi. 10.2105/AJPH.2018.304767
- By:
- Publication type:
- Article
No change in health-related quality of life for at-risk U.S. women and men starting HIV pre-exposure prophylaxis (PrEP): Findings from HPTN 069/ACTG A5305.
- Published in:
- PLoS ONE, 2018, v. 13, n. 12, p. 1, doi. 10.1371/journal.pone.0206577
- By:
- Publication type:
- Article
Daily Oral HIV Pre-exposure Prophylaxis Among Young Men Who Have Sex With Men in the United States: Cost-saving at Generic Drug Price.
- Published in:
- Clinical Infectious Diseases, 2024, v. 78, n. 2, p. 402, doi. 10.1093/cid/ciad566
- By:
- Publication type:
- Article
Self-Assessed Severity as a Determinant of Coronavirus Disease 2019 Symptom Specificity: A Longitudinal Cohort Study.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 1, p. e1180, doi. 10.1093/cid/ciac129
- By:
- Publication type:
- Article
Changes in Bone Mass After Discontinuation of Preexposure Prophylaxis With Tenofovir Disoproxil Fumarate/Emtricitabine in Young Men Who Have Sex With Men: Extension Phase Results of Adolescent Trials Network Protocols 110 and 113.
- Published in:
- Clinical Infectious Diseases, 2020, v. 70, n. 4, p. 687, doi. 10.1093/cid/ciz486
- By:
- Publication type:
- Article
Cabotegravir Is Not Associated With Weight Gain in Human Immunodeficiency Virus–uninfected Individuals in HPTN 077.
- Published in:
- Clinical Infectious Diseases, 2020, v. 70, n. 2, p. 319, doi. 10.1093/cid/ciz439
- By:
- Publication type:
- Article
Antiretroviral Concentrations in Hair Strongly Predict Virologic Response in a Large Human Immunodeficiency Virus Treatment-naive Clinical Trial.
- Published in:
- Clinical Infectious Diseases, 2019, v. 68, n. 6, p. 1044, doi. 10.1093/cid/ciy764
- By:
- Publication type:
- Article
Emergence of Integrase Resistance Mutations During Initial Therapy Containing Dolutegravir.
- Published in:
- Clinical Infectious Diseases, 2018, v. 67, n. 5, p. 791, doi. 10.1093/cid/ciy228
- By:
- Publication type:
- Article
HIV RNA Screening Reduces Integrase Strand Transfer Inhibitor Resistance Risk in Persons Receiving Long-Acting Cabotegravir for HIV Prevention.
- Published in:
- Journal of Infectious Diseases, 2022, v. 226, n. 12, p. 2170, doi. 10.1093/infdis/jiac415
- By:
- Publication type:
- Article
Assessing the Role of Long-Acting Cabotegravir Preexposure Prophylaxis of Human Immunodeficiency Virus: Opportunities and Aspirations.
- Published in:
- 2021
- By:
- Publication type:
- editorial
Evaluating group-sequential non-inferiority clinical trials following interim stopping: The HIV Prevention Trials Network 083 trial.
- Published in:
- Clinical Trials, 2022, v. 19, n. 6, p. 605, doi. 10.1177/17407745221118371
- By:
- Publication type:
- Article
Perspectives on preparing for long-acting injectable treatment for HIV among consumer, clinical and nonclinical stakeholders: A qualitative study exploring the anticipated challenges and opportunities for implementation in Los Angeles County.
- Published in:
- PLoS ONE, 2022, v. 17, n. 2, p. 1, doi. 10.1371/journal.pone.0262926
- By:
- Publication type:
- Article
Comparison of the Metabolic Effects of Ritonavir-Boosted Darunavir or Atazanavir Versus Raltegravir, and the Impact of Ritonavir Plasma Exposure: ACTG 5257.
- Published in:
- Clinical Infectious Diseases, 2016, v. 62, n. 12, p. 1842, doi. 10.1093/cid/civ193
- By:
- Publication type:
- Article
Comparison of the Metabolic Effects of Ritonavir-Boosted Darunavir or Atazanavir Versus Raltegravir, and the Impact of Ritonavir Plasma Exposure: ACTG 5257.
- Published in:
- Clinical Infectious Diseases, 2015, v. 60, n. 12, p. 1842, doi. 10.1093/cid/civ193
- By:
- Publication type:
- Article
Availability of HIV Postexposure Prophylaxis Services in Los Angeles County.
- Published in:
- Clinical Infectious Diseases, 2009, v. 48, n. 11, p. 1624, doi. 10.1086/598976
- By:
- Publication type:
- Article
PrEP Nonadherence, White Coat Dosing, and HIV Risk Among a Cohort of MSM.
- Published in:
- Open Forum Infectious Diseases, 2020, v. 7, n. 8, p. 1, doi. 10.1093/ofid/ofaa329
- By:
- Publication type:
- Article
Differentiating Nonoccupational Postexposure Prophylaxis Seroconverters and Non-Seroconverters in a Community-Based Clinic in Los Angeles, California.
- Published in:
- Open Forum Infectious Diseases, 2017, v. 4, n. 2, p. 1, doi. 10.1093/ofid/ofx061
- By:
- Publication type:
- Article
Screening for UGT1A1 Genotype in Study A5257 Would Have Markedly Reduced Premature Discontinuation of Atazanavir for Hyperbilirubinemia.
- Published in:
- Open Forum Infectious Diseases, 2015, v. 2, n. 3, p. 1, doi. 10.1093/ofid/ofv085
- By:
- Publication type:
- Article
Contingency Management Facilitates the Use of Postexposure Prophylaxis Among Stimulant-Using Men Who Have Sex With Men.
- Published in:
- Open Forum Infectious Diseases, 2015, v. 2, n. 1, p. 1, doi. 10.1093/ofid/ofu114
- By:
- Publication type:
- Article
Novel Approaches to Postnatal Prophylaxis to Eliminate Vertical Transmission of HIV.
- Published in:
- Global Health: Science & Practice, 2023, v. 11, n. 2, p. 1, doi. 10.9745/GHSP-D-22-00401
- By:
- Publication type:
- Article
Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2020 Recommendations of the International Antiviral Society-USA Panel.
- Published in:
- JAMA: Journal of the American Medical Association, 2020, v. 324, n. 16, p. 1651, doi. 10.1001/jama.2020.17025
- By:
- Publication type:
- Article
Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2018 Recommendations of the International Antiviral Society-USA Panel.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2016 Recommendations of the International Antiviral Society-USA Panel.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in low-risk HIV-uninfected individuals: HPTN 077, a phase 2a randomized controlled trial.
- Published in:
- PLoS Medicine, 2018, v. 15, n. 11, p. 1, doi. 10.1371/journal.pmed.1002690
- By:
- Publication type:
- Article
Safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in low-risk HIV-uninfected individuals: HPTN 077, a phase 2a randomized controlled trial.
- Published in:
- PLoS Medicine, 2018, v. 15, n. 11, p. 1, doi. 10.1371/journal.pmed.1002690
- By:
- Publication type:
- Article
Safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in low-risk HIV-uninfected individuals: HPTN 077, a phase 2a randomized controlled trial.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Low incidence and prevalence of hepatitis C in two cohorts of HIV pre‐exposure prophylaxis adherence interventions in men who have sex with men in Southern California.
- Published in:
- Journal of Viral Hepatitis, 2022, v. 29, n. 7, p. 529, doi. 10.1111/jvh.13678
- By:
- Publication type:
- Article
Quality of Care for HIV/AIDS and for Primary Prevention by HIV Specialists and Nonspecialists.
- Published in:
- AIDS Patient Care & STDs, 2016, v. 30, n. 9, p. 395, doi. 10.1089/apc.2016.0170
- By:
- Publication type:
- Article
A Novel Combination HIV Prevention Strategy: Post-Exposure Prophylaxis with Contingency Management for Substance Abuse Treatment Among Methamphetamine-Using Men Who Have Sex with Men.
- Published in:
- AIDS Patient Care & STDs, 2012, v. 26, n. 6, p. 320, doi. 10.1089/apc.2011.0432
- By:
- Publication type:
- Article
Sexual Risk Behaviors and Acceptability of HIV Pre-Exposure Prophylaxis Among HIV-Negative Gay and Bisexual Men in Serodiscordant Relationships: A Mixed Methods Study.
- Published in:
- AIDS Patient Care & STDs, 2012, v. 26, n. 2, p. 87, doi. 10.1089/apc.2011.0283
- By:
- Publication type:
- Article
Long term surgical outcomes for infective endocarditis in people who inject drugs: a systematic review and meta-analysis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Engagement with HIV and COVID-19 prevention: a national cross-sectional analysis of users on a geosocial networking app.
- Published in:
- Journal of Medical Internet Research, 2022, v. 24, n. 9, p. N.PAG, doi. 10.2196/38244
- By:
- Publication type:
- Article
Results from the post-exposure prophylaxis pilot program (P-QUAD) demonstration project in Los Angeles County.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Symptomatic Junctional Bradycardia After Treatment with Nelfinavir.
- Published in:
- Clinical Infectious Diseases, 1999, v. 29, n. 2, p. 449, doi. 10.1086/520237
- By:
- Publication type:
- Article
Novel Antiretroviral Agents.
- Published in:
- Current HIV/AIDS Reports, 2020, v. 17, n. 2, p. 118, doi. 10.1007/s11904-020-00486-2
- By:
- Publication type:
- Article
Current and Future PrEP Medications and Modalities: On-demand, Injectables, and Topicals.
- Published in:
- Current HIV/AIDS Reports, 2019, v. 16, n. 4, p. 349, doi. 10.1007/s11904-019-00450-9
- By:
- Publication type:
- Article
Using time‐weighted average change from baseline of SARS‐CoV‐2 viral load to assess impact of hydroxychloroquine as postexposure prophylaxis and early treatment for COVID‐19.
- Published in:
- Journal of Medical Virology, 2022, v. 94, n. 12, p. 6091, doi. 10.1002/jmv.28054
- By:
- Publication type:
- Article
Antiretroviral Therapy: Racial Disparities among Publicly Insured Californians with HIV.
- Published in:
- Journal of Health Care for the Poor & Underserved, 2017, v. 28, n. 1, p. 406, doi. 10.1353/hpu.2017.0031
- By:
- Publication type:
- Article
Quantifying the reduction in sexual transmission of HIV-1 among MSM by early initiation of ART: A mathematical model.
- Published in:
- PLoS ONE, 2020, v. 15, n. 7, p. 1, doi. 10.1371/journal.pone.0236032
- By:
- Publication type:
- Article
Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2022 Recommendations of the International Antiviral Society-USA Panel.
- Published in:
- 2023
- By:
- Publication type:
- journal article
Cost-Effectiveness of Long-Acting Injectable HIV Preexposure Prophylaxis in the United States : A Cost-Effectiveness Analysis.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Hydroxychloroquine as Postexposure Prophylaxis to Prevent Severe Acute Respiratory Syndrome Coronavirus 2 Infection : A Randomized Trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Safety and Tolerability of Maraviroc-Containing Regimens to Prevent HIV Infection in Women: A Phase 2 Randomized Trial.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Three Nonnucleoside Reverse Transcriptase Inhibitor-Sparing Antiretroviral Regimens for Treatment-Naive Volunteers Infected With HIV-1.
- Published in:
- 2015
- By:
- Publication type:
- Journal Article
Three Nonnucleoside Reverse Transcriptase Inhibitor–Sparing Antiretroviral Regimens for Treatment-Naive Volunteers Infected With HIV-1.
- Published in:
- Annals of Internal Medicine, 2015, v. 162, n. 6, p. 461, doi. 10.7326/L15-5066-3
- By:
- Publication type:
- Article
Efficacy and tolerability of 3 nonnucleoside reverse transcriptase inhibitor-sparing antiretroviral regimens for treatment-naive volunteers infected with HIV-1: a randomized, controlled equivalence trial.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Efficacy and Tolerability of 3 Nonnucleoside Reverse Transcriptase Inhibitor-Sparing Antiretroviral Regimens for Treatment-Naive Volunteers Infected With HIV-1.
- Published in:
- Annals of Internal Medicine, 2014, v. 161, n. 7, p. 461, doi. 10.7326/M14-1084
- By:
- Publication type:
- Article
A population pharmacokinetic model based on HPTN 077 of long‐acting injectable cabotegravir for HIV PrEP.
- Published in:
- British Journal of Clinical Pharmacology, 2022, v. 88, n. 10, p. 4623, doi. 10.1111/bcp.15477
- By:
- Publication type:
- Article
Population pharmacokinetics of cabotegravir following administration of oral tablet and long‐acting intramuscular injection in adult HIV‐1‐infected and uninfected subjects.
- Published in:
- British Journal of Clinical Pharmacology, 2022, v. 88, n. 10, p. 4607, doi. 10.1111/bcp.15439
- By:
- Publication type:
- Article
Perspectives of US women participating in a candidate PrEP study: adherence, acceptability and future use intentions.
- Published in:
- Journal of the International AIDS Society, 2019, v. 22, n. 3, p. N.PAG, doi. 10.1002/jia2.25247
- By:
- Publication type:
- Article